Antigen Rapid Testing (20 Tests)
Our Rapid Antigen Test is certified and accredited within the EU and is currently in use in the public and private EU healthcare sector. CE Marked, it is also in use in the wider EU economy in construction, hospitality, nursing homes, sport and airports. For more information on Rapid Antigen Testing view EU document and HIQA document.
This next generation Covid-19 testing technology has evolved as part of the worldwide fight against Covid-19 and carries with it the credibility of worldwide scientific research.
Our rapid antigen test can be a game changer in the fight against Covid-19 and the efforts to safely reopen our economy.
It offers accurate testing technology at an affordable price. It’s ability to recognise high levels of infectiousness, in a 15-minute results format, makes it a reliable tool in helping our economy to return to work in a safe way.
It can help to restore public confidence and facilitate a steady return to social normality. Like a mask or social distancing, this is one of many Covid-19 solutions that will help us to help combat Coronavirus, The cost profile makes it a viable mass testing opportunity for the Irish economy.
HPRA guidance on Covid tests: https://www.hpra.ie/homepage/medical-devices/covid-19-updates/in-vitro-diagnostic-(ivd)-tests-for-covid-19
HSE – Interim guidance on the use of Antigen Detection Tests (ADTs) in the public health system in Ireland: https://www.hpsc.ie/az/respiratory/coronavirus/novelcoronavirus/guidance/laboratoryguidance/Guidance%20on%20use%20of%20ADT%20in%20the%20public%20health%20system.pdf